PP2B Activators

PP2B Activators are comprised of a diverse array of chemical compounds that indirectly promote the functional activity of PP2B through a variety of signaling pathways. Ionophores like A23187 (Calcimycin) directly increase cytosolic calcium levels, which is crucial for PP2B's calcium-dependent phosphatase activity, leading to its activation. Similarly, agents thatincrease cyclic AMP levels, such as Forskolin, Dibutyryl-cAMP, Isoproterenol, and Vasoactive Intestinal Peptide, indirectly facilitate PP2B activation. These compounds engage adenylate cyclase, culminating in PKA activation, which then influences the phosphorylation status of proteins that interact with PP2B, potentially augmenting its activity. Moreover, the Vitamin D analog Calcipotriol and the L-type calcium channel agonist BAY K 8644 modulate intracellular calcium levels, further supporting PP2B activation due to its calcium reliance. Nicardipine, although classically known as a calcium channel blocker, can under certain circumstances result in elevated intracellular calcium, thereby enhancing PP2B activity. Thapsigargin contributes to this calcium-centric theme by inhibiting the SERCA pump, resulting in increased cytosolic calcium and subsequent PP2B activation.

The intricate balance of protein phosphatase activity within cells is subtly influenced by compounds such as Okadaic Acid, which at specific concentrations may indirectly increase PP2B activity by inhibiting PP2A, a phosphatase that often acts in opposition to PP2B. (−)-Epigallocatechin Gallate, widely recognized for its broad spectrum of biological effects, might influence PP2B activity through its interaction with multiple cellular signaling pathways, although the exact mechanisms remain to be thoroughly elucidated. Lastly, PMA, known as a PKC activator, has the potential to induce phosphorylation of proteins that regulate PP2B, including its inhibitors, thereby promoting PP2B activation. Collectively, these PP2B activators, through their targeted effects on cellular signaling, indirectly but effectively potentiate the activity of PP2B without directly modifying its expression levels or engaging in direct activation mechanisms.